Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
Named as key players in the same markets as Otsuka Holdings Co Ltd (number of shared markets).
AbbVie Inc.1 shared market
AstraZeneca1 shared market
Bausch Health1 shared market
Bayer AG1 shared market
Celltrion Healthcare Co1 shared market
GSK PLC1 shared market
Johnson & Johnson1 shared market